CELL ALPHA
LIVE

Serial Number

98251880

Owner

Cellares Corporation

Attorney

Bobby A. Ghajar

Filing Date

Nov 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CELL ALPHA Trademark

Serial Number: 98251880

CELL ALPHA is a trademark filed by Cellares Corporation on November 2, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Cellares Corporation (38 trademarks)

South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

November 2, 2023

Registration Date

Not Registered

Published for Opposition

August 6, 2024

Goods & Services

Bioprocessing equipment in the nature of scientific systems for bioprocessing of cellular material and performing fluidic transfers comprised of computer hardware, recorded software, bioprocessing instruments in the nature of pumps, elutriators, magnetic separators, and electroporators, and disposables in the nature of cartridges including mixers, impellers, and bioreactors, all of the aforementioned equipment sold as a unit for the manufacturing of therapeutics and biologics-based drug delivery vehicles; Downloadable computer software for accessing a database featuring information in the medical field, specifically, cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; Scientific and laboratory apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies in the nature of laboratory centrifuges, cell sorting apparatus, bioreactors for laboratory use, and parts and fittings for all of the aforesaid goods; Fully integrated laboratory apparatus and computer systems, namely, computer systems comprised of a graphical user interface, processor, and server for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Downloadable software for the manufacturing of autologous and allogeneic cell therapies; Downloadable software for automating the operations of biotechnological instruments used with manufacturing equipment for biological cell therapies; Downloadable software for the execution, monitoring, analysis of cell therapy manufacturing workflows as well as process development workflows; Downloadable software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material, namely, allogeneic and autologous cells; Downloadable software for generating electronic batch records for cell therapies

Medical equipment in the nature of an instrument docking station and a cartridge for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system, namely, a fluidic transfer system, chambers for cell processing, and corresponding instrumentation including a fluidic transfer system, chambers for cell processing, and corresponding instrumentation for use in the creation of biological cell therapies for medical purposes; Medical bags and containers in the nature of disposable single-use containers adapted for and sold for solutions used for the manufacturing of autologous and allogeneic biological cell therapies for medical use, namely, bags, pouches, cartridges, namely, for transferring and/or processing of allogeneic or autologous cellular material; rigid and semi-rigid containers for concentrates and solutions in solid or liquid form, all of the aforesaid being for medical use; the foregoing excludes containers that are used to transport or ship temperature-sensitive goods, medicines, pharmaceuticals, and biologics in an insulated- or temperature-controlled manner

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 26, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 26, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 20, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 20, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 20, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2024 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 1, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 20, 2023 NWOS
NEW APPLICATION ENTERED
Nov 6, 2023 NWAP